{"Ticker": "OGN", "Company": "Organon & Co.", "Sector": "Health Care", "Updated": "2023-09-21", "Rating": [{"Date": "2023-09-21", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Overweight", "Target_Change": "$28"}, {"Date": "2023-03-16", "Rating": "Initiated", "Organization": "Raymond James", "Rating_Change": "Outperform", "Target_Change": "$33"}, {"Date": "2022-10-14", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Neutral to Underperform", "Target_Change": "$27 to $25"}, {"Date": "2022-09-06", "Rating": "Upgrade", "Organization": "Piper Sandler", "Rating_Change": "Neutral to Overweight", "Target_Change": "$37 to $34"}, {"Date": "2022-08-05", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Neutral", "Target_Change": "$40 to $37"}, {"Date": "2022-04-27", "Rating": "Initiated", "Organization": "Goldman", "Rating_Change": "Buy", "Target_Change": "$40"}, {"Date": "2022-04-06", "Rating": "Resumed", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight", "Target_Change": "$35"}, {"Date": "2021-10-07", "Rating": "Initiated", "Organization": "Piper Sandler", "Rating_Change": "Neutral", "Target_Change": "$35"}, {"Date": "2021-09-01", "Rating": "Initiated", "Organization": "BofA Securities", "Rating_Change": "Buy", "Target_Change": "$43"}, {"Date": "2021-07-22", "Rating": "Initiated", "Organization": "Citigroup", "Rating_Change": "Buy", "Target_Change": "$35"}, {"Date": "2021-06-15", "Rating": "Initiated", "Organization": "JP Morgan", "Rating_Change": "Neutral", "Target_Change": "$38"}, {"Date": "2021-06-11", "Rating": "Initiated", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight", "Target_Change": "$33"}, {"Date": "2021-06-10", "Rating": "Initiated", "Organization": "Evercore ISI", "Rating_Change": "Outperform", "Target_Change": ""}]}